CHARLOTTE, N.C., Feb. 5, 2013 -- Solanbridge Group, Inc. (OTC.PK: SLNX) is pleased to announce that it has had any shares issued pursuant to the exemption found in Rule 504 returned to the Company's treasury. The current management of Solanbridge Group, Inc. also discovered that the prior management of the Company made a calculation error related to the Company's freely tradable share structure, which is currently 17,234,746 and has remained unchanged since new management has taken control.
Solanbridge Group, Inc. also announces it has accepted the resignation of Matthew Nicoletti from all of his positions with the company on January 31, 2013.
About Solanbridge Group, Inc:
Solanbridge Group, Inc. is an investment company and diversified holding company whose main business is purchasing revenue generating foreign and domestic private/public companies. Solanbridge Group is currently comprised of two subsidiaries, Advanced Medical Sales LLC and Adventure Option, Inc.
Advanced Medical Sales supplies Transcutaneous Electrical nerve stimulators, Therapeutic Deep Tissue Ultrasound units, Micro-current sub sensory units and Electric Muscle stimulation units along with numerous joint and extremity therapeutic sleeves directly to Physicians offices, Chiropractic offices and Physical Therapy Centers. The devices are used for the treatment of acute and chronic pain as well as post-operatively for muscle rehabilitation either with or without prescribed Narcotic Analgesics, NSAIDS, Muscle Relaxants and/or steroids depending on each patient's specific needs and/or wishes. The Medical Provider prescribes and fits the patient with one or more of these devices with respect to the Medical Necessity of the patient. Electrodes are sent to maintain the proper use of the equipment monthly to each patient by Advanced Medical and reimbursement to Advanced Medical is made by the patient's insurance company. With the very recent regulations by Governmental and State Medical Boards to limit the prescribing of Pain Medication by Physicians and the policing of Physician's prescribing habits by Electronic Narcotic Prescription Databases, there has been a growing concern on the part of Physicians and increasing pressure on Medical Boards by patient advocacy groups to make significant changes.The above facts, coupled with the recent realization of the harmful Cardiovascular effects of all NSAIDS, the changes of commonly used muscle relaxants from general RX's to Controlled substances (i.e. SOMA) and the many adverse effects from the use of Steroids have presented Advanced Medical with the opportunity to be a leader in the areas of Pain Management and Post Operative Rehabilitation.
Solanbridge's wholly owned subsidiary, Adventure Option, Inc., has an extensive background in the sex life enhancement industry. The company has formulated some of the most exciting products in the industry today, which include Morning Glory (male arousal capsule) and Evening Delight (Female arousal gel) formulas . Adventure Option's library of formulas consists of over 40 products that can be customized to meet your company's needs. The Company plans on taking its new products to market within the next twelve months and is set to move its headquarters to Charlotte, North Carolina.
SOURCE Solanbridge Group, Inc.